Healix Pathology, LLP

Dr. Peter Bryant-Greenwood

MD, MBA

Peter Bryant-Greenwood MD, MBA has 25 years of leadership experience in molecular diagnostics and personalized medicine.  After completing his residencies and fellowships at the Laboratory of Pathology, National Cancer Institute (NIH), and the Center for Biologics, Evaluation and Research (FDA), he spent 13 years as Director of Laboratory Services and Medical Director of Comprehensive Genetics and Molecular Diagnostics at the Queens Medical Center, Hawaii and Executive Vice Chair, Dept. of Pathology, John A Burns School of Medicine.  employers, and health-related entities making testing available directly to patients.

In 2017 Dr. Bryant-Greenwood joined National Jewish Health, Denver Colorado as Medical Director of Advanced Diagnostic Laboratories, : an integrated group of laboratories specializing in CRO and esoteric referral testing encompassing Immunology, pharmacokinetics, Complement, Microbiology, Mycobacteriology, Molecular Diagnostics and Clinical Chemistry. 

an innovative and simple platform ...

Presently, Dr. Bryant-Greenwood is CMO, CMIO and Laboratory Director of Phase2 Laboratories in Nashville Tennessee- a laboratory dedicated to the combined diagnostic and therapeutic management of acute and chronic respiratory disease such as COPD, Asthma, Interstitial lung disease, cystic fibrosis and ARDS.  Additionally, Dr. Bryant-Greenwood is the managing partner of Healix Pathology LLP in Houston, Texas which is dedicated to integrated wound care diagnostics.    

Dr. Bryant-Greenwood is a Fellow of the College of American Pathologists and a Fellow of the American College of Healthcare Executives.

Additionally, we have deployed a LIM system that facilitates lab-to-lab connectivity for ordering and result delivery.  It provides an innovative and simple platform that facilitates high-volume testing from scheduling sample collection at a site, accessioning at collection, attaching the sample securely to that patient in the LIM system and ultimately, delivery of test results directly to patients and/or employers/agencies via secure login to view/download results. 

Our LIM platform offers a provider (prescriber) portal for digital ordering and accessioning, as well as results review/download and secure fax.